Genetic link to COPD: MMP9 gene study
Part of Lungs & breathing clinical trials.
This study looks at a gene (MMP9) that may be linked to COPD. It aims to understand how genetic differences affect the disease, which could help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have long-term symptoms like cough, shortness of breath, or wheezing.
- Your lung function test (spirometry) shows your FEV1 is less than 80% of normal and the ratio of FEV1 to FVC is less than 70%.
- After using a rescue inhaler, your FEV1 does not improve by more than 12%.
- You do not have asthma or a history of asthma.
- You have smoked cigarettes or other tobacco products at some point.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how bacteria in your body and other chemicals relate to COPD. It compares people with COPD to healthy smokers to find differences.
This study measures a protein called SLC25A48 in people with COPD (a lung condition that makes breathing hard) and in healthy people to learn if it plays a role in the disease.
This study looks at a lung protein called MMP12 in sputum (mucus) to better understand COPD. It may help researchers learn which COPD changes are linked to disease severity and lung damage.
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
This study looks at signs (biomarkers) and different types of COPD in Chinese people. It aims to better understand COPD and pre-COPD, which may help with future treatments.
This study is looking at how mucus builds up in the airways of people with asthma, COPD, or chronic cough. Researchers will also compare findings to healthy volunteers. The goal is to better understand these conditions and find new ways to help.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.